AAD mourns the loss of board member and investor James Herbert
28 Mar 2024
Executive Change
Herbert credited with helping to set AAD up for success
MORRISVILLE, N.C., March 28, 2024 /PRNewswire/ -- With sadness, AAD announced today that its influential board member and investor James Herbert has died following a lengthy battle with cancer. He was 83.
Herbert joined AAD's board in February 2021 after first making an investment in the company. Under his guidance, AAD recreated itself to consist of sister companies Advanced Animal Diagnostics, an animal diagnostics and data systems company, and Ad Astra Diagnostics, which is focused on human point-of-care diagnostics.
Continue Reading
Preview
Source: PRNewswire
Mr. James Herbert, AAD Board Member and investor, has died.
Herbert was the retired founder, CEO and chairman of Lansing, Michigan-based Neogen Corporation. Herbert guided Neogen from its founding in 1982 to more than $400 million in annual revenues and a market capitalization of more than $4 billion. Under Herbert's leadership, Neogen's portfolio of products and services grew to include innovative food safety and human diagnostics, animal health products, and animal genomics services.
"He was a great example for and avid supporter of entrepreneurs," said Joy Parr Drach, president and CEO of both AAD companies. "Mr. Herbert lived what we are working very hard to accomplish at AAD, and he provided us with the invaluable guidance we needed to position ourselves to succeed. At once, he was an investor, Texas cattle rancher, CEO of a company that produces animal and human diagnostics, and a board member of a large health system that consists of several hospitals. He was the perfect person at the perfect time for AAD. His memory and contributions will endure forever."
Herbert was a board member and with his wife, Judi, major donors of Lansing-based Sparrow, which includes the Herbert-Herman Cancer Center. Parr Drach credited Herbert with providing critical assistance in validating AAD’s human diagnostics in real-world environments.
"A lot of the early work in proving our products was done at Sparrow Hospital in Lansing because of Mr. Herbert," she said. "There, we learned we could improve the patient care and provider experience, often in very difficult and emotional situations, by quickly providing accurate diagnostic results patient-side. Mr. Herbert believed in what we could accomplish and was instrumental in helping us prove it."
About Ad Astra DiagnosticsAd Astra Diagnostics
Ad Astra Diagnostics, Inc. provides rapid point-of-care diagnostics to enable fast health decisions. The company's QScout™ system was designed to improve health, well-being and lab efficiency. Ad Astra's name, the Latin translation of "to the stars", embodies the company's vision for democratizing diagnostic access and pays homage to techniques rooted in astronomy.
Advanced Animal Diagnostics provides livestock producers with rapid point-of-care diagnostic and data systems that improve profitability and empower precise care of animals, so they live healthier, more productive lives. AAD tests provide actionable information to inform real-time decisions that increase productivity, prevent losses, protect the food supply, reduce antibiotic use and improve human and animal well-being.
Media contact:
[email protected]
SOURCE Advanced Animal Diagnostics
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.